Announce Date | 05/02/2025 |
EPS Normalized Actual | $1.82 (Miss by $-0.02) |
EPS GAAP Actual | $1.82 (Miss by $-0.02) |
Revenue Actual | $5.548B |
Revenue Surprise | Beat by $5548M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $2.20407 |
EPS GAAP Estimate | $2.20407 |
Revenue Estimate | $0.988025B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 0 | INF | 0 | 0 | 3 |
Dec 2028 | 0 | INF | 0 | 0 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.68 | 0.68 | 5.548B | -28.05% | 5548M |
FQ4 2024 (Dec 2024) | 2.13 | 2.13 | 5.283B | -110.15% | 5283M |
FQ3 2024 (Sep 2024) | 4.1 | 4.1 | 7.773B | 66.62% | 7773M |
FQ2 2024 (Jun 2024) | 1.4 | 1.4 | 6.081B | -125.32% | 6081M |
FQ1 2024 (Mar 2024) | 2.43 | 2.43 | 7.104B | 25.38% | 7104M |
FQ4 2023 (Dec 2023) | 4.8 | 4.8 | 11.102B | 56.39% | 11102M |
FQ3 2023 (Sep 2023) | 1.14 | 1.14 | 2.595B | -14.8% | 2595M |
FQ2 2023 (Jun 2023) | 1.03 | 1.03 | 13.702B | 83.42% | 13702M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
2.20407
Consensus Revenue Estimates
0.988025B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 3.1793 | -- | 3.05388 | 3.27785 | 8 |
FQ3 2027 (Sep 2027) | 2.9915 | -- | 2.87349 | 3.08423 | 8 |
FQ2 2027 (Jun 2027) | 2.8637 | -- | 2.75073 | 2.95247 | 8 |
FQ1 2027 (Mar 2027) | 2.6654 | -- | 2.56026 | 2.74802 | 8 |
FQ4 2026 (Oct 2026) | 2.64026 | -- | 2.60241 | 2.68566 | 3 |
FQ3 2026 (Jul 2026) | 2.55517 | -- | 2.51854 | 2.59911 | 3 |
FQ2 2026 (Jun 2026) | 2.4897 | -- | 2.46994 | 2.50441 | 3 |
FQ1 2026 (Mar 2026) | 2.41082 | 71.79 | 2.39169 | 2.42507 | 6 |
FQ4 2025 (Oct 2025) | 2.31539 | 8.01 | 2.2822 | 2.3552 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 40.48B | -- | 39.25B | 41.44B | 4 |
FQ3 2027 (Sep 2027) | 35.65B | -- | 34.57B | 36.5B | 4 |
FQ2 2027 (Jun 2027) | 31.4B | -- | 30.45B | 32.15B | 4 |
FQ1 2027 (Mar 2027) | 27.66B | -- | 26.82B | 28.32B | 4 |
FQ4 2026 (Oct 2026) | 15.04B | -- | 14.87B | 15.24B | 1 |
FQ3 2026 (Jul 2026) | 13.95B | -- | 13.8B | 14.14B | 1 |
FQ2 2026 (Jun 2026) | 38.86B | -- | 38.62B | 39.03B | 1 |
FQ1 2026 (Mar 2026) | 36.08B | 84.62 | 35.86B | 36.25B | 1 |
FQ4 2025 (Oct 2025) | 1.02B | -418.95 | 1.01B | 1.03B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.68 | 0.68 | 100% | |
FQ4 2024 (Dec 2024) | 2.13 | 2.13 | 100% | |
FQ3 2024 (Sep 2024) | 4.1 | 4.1 | 100% | |
FQ2 2024 (Jun 2024) | 1.4 | 1.4 | 100% | |
FQ1 2024 (Mar 2024) | 2.43 | 2.43 | 100% | |
FQ4 2023 (Dec 2023) | 4.8 | 4.8 | 100% | |
FQ3 2023 (Sep 2023) | 1.14 | 1.14 | 100% | |
FQ2 2023 (Jun 2023) | 1.03 | 1.03 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $5.55B | $5548M | 100% |
FQ4 2024 (Dec 2024) | $0B | $5.28B | $5283M | 100% |
FQ3 2024 (Sep 2024) | $0B | $7.77B | $7773M | 100% |
FQ2 2024 (Jun 2024) | $0B | $6.08B | $6081M | 100% |
FQ1 2024 (Mar 2024) | $0B | $7.1B | $7104M | 100% |
FQ4 2023 (Dec 2023) | $0B | $11.1B | $11102M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.6B | $2595M | 100% |
FQ2 2023 (Jun 2023) | $0B | $13.7B | $13702M | 100% |